Tedros Adhanom Ghebreyesus, Director General of the WHO (Denis Balibouse/Pool Photo via AP Images)
Bavarian Nordic nabs EU approval for monkeypox vaccine as WHO declares global health emergency
As the WHO declared the monkeypox outbreak to be a global health emergency, Bavarian Nordic obtained an expanded European label for its smallpox vaccine to include the surging virus.
The move comes roughly a month after the biotech filed for a label expansion, and after several countries on the continent, and elsewhere, secured their own supply deals for the shot. Bavarian Nordic has said it’s seen “overwhelming” interest in the vaccine, and its stock price $BVRNY has followed in short order — shares are up 124% since the first monkeypox case was detected on May 6.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters